Franklin Biotechnology Discovery Fund

Portfolio Statistics

Assets

Total Fund AssetsAs of 10/31/2019 (updated monthly) $1,084.2 (M)
Net Assets - Class C As of 09/30/2019 (updated monthly) $40.2 (M)

Positions As of 10/31/2019

Equity VS. NASDAQ Biotechnology Index

Fund Benchmark
Market CapitalizationAs of 10/31/2019 (updated monthly) $28,661.54(M) $36,639.11(M)
P/B RatioAs of 10/31/2019 (updated monthly) 5.41 4.69
P/E Ratio (12-mo Forward)As of 10/31/2019 (updated monthly) 15.69 13.85
Price to Cash FlowAs of 10/31/2019 (updated monthly) 16.30 14.62

Portfolio Details

Asset AllocationAs of 10/31/2019

[name] [value]
Equity 98.02%
Cash & Cash Equivalents 1.98%

Geographic BreakdownAs of 10/31/2019

[name] [value]
United States 85.31%
United Kingdom 4.25%
Netherlands 3.05%
Denmark 2.63%
Cash & Cash Equivalents 1.98%
Canada 1.07%
Switzerland 0.77%
Germany 0.69%
Ireland 0.25%

sector breakdownAs of 10/31/2019

[name] [value]
Biotechnology 79.30%
Pharmaceuticals 13.92%
Life Sciences Tools & Services 4.80%
Cash & Cash Equivalents 1.98%

TOP TEN HOLDINGSAs of 10/31/2019

Issuer Country Industry % of total
AMGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 8.10%
VERTEX PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.80%
GILEAD SCIENCES INC United States Pharmaceuticals, Biotechnology & Life Sciences 6.12%
BIOGEN INC United States Pharmaceuticals, Biotechnology & Life Sciences 5.21%
ILLUMINA INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.80%
REATA PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.61%
GW PHARMACEUTICALS PLC United Kingdom Pharmaceuticals, Biotechnology & Life Sciences 4.25%
REGENERON PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 4.05%
IOVANCE BIOTHERAPEUTICS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.88%
ALEXION PHARMACEUTICALS INC United States Pharmaceuticals, Biotechnology & Life Sciences 3.31%

Market Capitalization BreakdownAs of 10/31/2019

[name] [value]
<2.0 Billion 18.82%
2.0-5.0 Billion 23.94%
5.0-10.0 Billion 15.39%
10.0-25.0 Billion 5.73%
25.0-50.0 Billion 9.03%
>50.0 Billion 26.77%
N/A 0.32%